293b cpd has been researched along with toxin ii (anemonia sulcata) in 3 studies
| Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (toxin ii (anemonia sulcata)) | Trials (toxin ii (anemonia sulcata)) | Recent Studies (post-2010) (toxin ii (anemonia sulcata)) |
|---|---|---|---|---|---|
| 100 | 0 | 16 | 142 | 1 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antzelevitch, C; Shimizu, W | 2 |
| Belardinelli, L; Shryock, JC; Song, Y; Wu, L | 1 |
3 other study(ies) available for 293b cpd and toxin ii (anemonia sulcata)
| Article | Year |
|---|---|
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chromans; Cnidarian Venoms; Disease Models, Animal; Dogs; Electrocardiography; Heart Conduction System; Heart Rate; Heart Ventricles; Isoproterenol; Long QT Syndrome; Neurotoxins; Potassium Channel Blockers; Propranolol; Sotalol; Sulfonamides; Sympathetic Nervous System; Treatment Outcome | 2000 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Topics: Acetanilides; Action Potentials; Animals; Chromans; Cnidarian Venoms; Delayed Rectifier Potassium Channels; Drug Synergism; Drug Therapy, Combination; Female; Guinea Pigs; Heart Conduction System; Heart Ventricles; Ion Channel Gating; Long QT Syndrome; Male; Myocytes, Cardiac; Piperazines; Piperidines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Potassium Channels, Voltage-Gated; Pyridines; Ranolazine; Sodium Channels; Sulfonamides; Tetrodotoxin; Time Factors | 2004 |